Lactobacillus paracasei Jlus66 relieves DSS-induced ulcerative colitis in a murine model by maintaining intestinal barrier integrity, inhibiting inflammation, and improving intestinal microbiota structure
Authors:
- 11 May 2024
- journal article
- research article
- Published by Springer Nature in European Journal of Nutrition
- Vol. 63 (6) , 2185-2197
Abstract
Purpose Ulcerative colitis (UC) is a serious health problem with increasing morbidity and prevalence worldwide. The pathogenesis of UC is complex, currently believed to be influenced by genetic factors, dysregulation of the host immune system, imbalance in the intestinal microbiota, and environmental factors. Currently, UC is typically managed using aminosalicylates, immunosuppressants, and biologics as adjunctive therapies, with the risk of relapse and development of drug resistance upon discontinuation. Therefore, further research into the pathogenesis of UC and exploration of potential treatment strategies are necessary to improve the quality of life for affected patients. According to previous studies, Lactobacillus paracasei Jlus66 (Jlus66) reduced inflammation and may help prevent or treat UC. Methods We used dextran sulfate sodium (DSS) to induce a mouse model of UC to assess the effect of Jlus66 on the progression of colitis. During the experiment, we monitored mouse body weight, food and water consumption, as well as rectal bleeding. Hematoxylin-eosin staining was performed to assess intestinal pathological damage. Protein imprinting and immunohistochemical methods were used to evaluate the protein levels of nuclear factor-kappa B (NF-κB), mitogen-activated protein kinase (MAPK), and tight junction (TJ) proteins in intestinal tissues. Fecal microbiota was analyzed based on partial 16S rRNA gene sequencing. Results Jlus66 supplementation reduced the degree of colon tissue damage, such as colon shortening, fecal occult blood, colon epithelial damage, and weight loss. Supplementation with Jlus66 reduced DSS-induced upregulation of cytokine levels such as TNF-α, IL-1β, and IL-6 (p < 0.05). The NF-κB pathway and MAPK pathway were inhibited, and the expression of TJ proteins (ZO-1, Occludin, and Claudin-3) was upregulated. 16S rRNA sequencing of mouse cecal contents showed that Jlus66 effectively regulated the structure of the intestinal biota. Conclusion In conclusion, these data indicate that Jlus66 can alter the intestinal biota and slow the progression of UC, providing new insights into potential therapeutic strategies for UC.Keywords
Funding Information
- Interdisciplinary Integration and Innovation Project of JLU (Interdisciplinary Integration and Innovation Project of JLU)
- Fundamental Research Funds for Central Universities of the Central South University (Fundamental Research Funds for Central Universities of the Central South University)
This publication has 44 references indexed in Scilit:
- Activity of inflammatory bowel disease influences the expression of cytokines in gingival tissueCytokine, 2017
- Gleaning Insights from Fecal Microbiota Transplantation and Probiotic Studies for the Rational Design of Combination Microbial TherapiesClinical Microbiology Reviews, 2017
- Gastrointestinal mucosal barrier function and diseasesJournal of Gastroenterology, 2016
- Real-life Treatment Paradigms Show Infliximab Is Cost-effective for Management of Ulcerative ColitisClinical Gastroenterology and Hepatology, 2014
- Inflammatory Bowel Disease as a Model for Translating the MicrobiomeImmunity, 2014
- Intestinal barrier function in neonatal foals: Options for improvementThe Veterinary Journal, 2012
- Claudins and Other Tight Junction Proteins2012
- Synergy of IL-23 and Th17 Cytokines: New Light on Inflammatory Bowel DiseaseNeurochemical Research, 2009
- Subclinical Intestinal Inflammation in Patients with Crohn’s Disease Following Bowel Resection: A Smoldering FireJournal of Gastrointestinal Surgery, 2009
- Colitis in mice lacking the common cytokine receptor γ chain is mediated by IL-6-producing CD4+ T cellsGastroenterology, 2005